Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) [NA]
A clinical trial update for a physical activity intervention (Fit4Treatment) in older women with gynecologic cancers, currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics [NA]
Emory University is conducting a study to evaluate an evidence-based family history screening program designed to increase uptake of BRCA-as…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating SBRT-LDRT with cadonilimab for advanced gastric, colorectal, and ovarian cancers with peritoneal…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients [Phase 1, Phase 2]
First-in-human Phase 1/2 trial of an autologous dendritic cell vaccine targeting Wilms' tumor protein 1 (WT1) with interleukin-15 trans-pres…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Evolution of the Therapeutic Care in Ovarian Cancer From 2011
This update notes that the UNICANCER-sponsored ovarian cancer trial NCT03275298 is currently suspended, reflecting an ongoing reassessment o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment [Phase 3]
This clinical trial update reports a Phase 3 study evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for relapsed ovarian epithel…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics [Phase 1]
A Phase 1 trial evaluating ribociclib plus belinostat for metastatic triple-negative breast cancer and recurrent ovarian cancer, with genomi…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy [Phase 2]
Phase 2 trial evaluating SBRT alone or followed by Niraparib for recurrent ovarian cancer with oligometastases or oligoprogression after PAR…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer [Phase 3]
This update notes a Phase 3 trial evaluating relacorilant in combination with nab-paclitaxel for advanced platinum-resistant ovarian, primar…
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Ongoing University of Alberta-sponsored LONGEVITI study, LIVInG With chrONic Cancer TrEatments, is currently recruiting to evaluate cancer t…
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: Exosome-based Recurrence Score for Post-Treatment Ovarian Cancer
Clinical trial exploring an exosome-based recurrence score for post-treatment ovarian cancer; recruitment has not yet begun.
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial update for Mirvetuximab soravtansine (IMGN853) in FRα-high recurrent ovarian, fallopian tube, or primary peritoneal…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer
A clinical trial at University Hospital Strasbourg is evaluating whether a paradigm shift in the therapeutic strategy improves survival for …
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Clinical Study of TCR-like CAR-T Cell Targeted MSLN in the Treatment of Ovarian Cancer [Phase 1, Phase 2]
Clinical trial update for a Phase 1/2 study of TCR-like CAR-T cells targeting mesothelin in ovarian cancer; the trial is currently active bu…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors [NA]
Phase I clinical trial evaluating CAR-T cell therapy for advanced gynecologic solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Combined Intraperitoneal Chemotherapy Regimen After Optimal Interval Surgery in Advanced Ovarian Cancer: BICOV-1 (Bidirectional Chemotherapy in Ovarian Cancer) [NA]
Clinical trial update for the BICOV-1 study evaluating bidirectional intraperitoneal chemotherapy after optimal interval surgery in advanced…
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: A Study of Niraparib in Combination With Abemaciclib for Late Line Treatment of Ovarian Cancer (NICHOL TRIAL) [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the combination of niraparib with abemaciclib for late-line ovarian cancer and is currently recruit…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Ultrasound-guided Tru-cut Biopsy in Patients with Suspected Ovarian Cancer: Adequacy, Accuracy, Safety and Patient Assessment.
This clinical trial update evaluates ultrasound-guided Tru-cut biopsy in patients with suspected ovarian cancer to assess tissue adequacy, d…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Laparoscopic Interval Cytoreductive Surgery in Advance Ovarian Cancer [NA]
This clinical trial entry describes a recruiting study evaluating laparoscopic interval cytoreductive surgery for advanced ovarian cancer.
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian Cancer [Phase 2]
Phase 2 clinical study evaluating Fasudil Hydrochloride for gene-specific ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Lipid Mediators & Cancer: Montelukast, SPM, and Almonds [EARLY_Phase 1]
This early Phase 1 clinical trial from the University of South Florida investigates montelukast, specialized pro-resolving mediators, and al…
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial updates the investigation of DC05F01 in Chinese patients with recurrent or refractory ovarian cancer and other advanced …
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: METR-NK Cells in Combination With Anti-angiogenic Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating METR-NK cells in combination with anti-angiogenic neoadjuvant therapy for advanced epithelial ovarian ca…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer [Phase 2, Phase 3]
Clinical trial investigating pegylated liposomal doxorubicin plus adebrelimab with or without mirabegron for relapsed ovarian cancer; Phase …
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer [Phase 2]
An exploratory, multi-cohort Phase II trial evaluating the combination of AK104 and AK112 for recurrent ovarian cancer is currently recruiti…